Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.
To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html
The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments:
· Type of Modular Construct
§ Hybrid Skid
§ Plug-and-Play
§ Skid-Mounted
§ Truckable
§ Others
§ Type of Construction Component
§ Base Building
§ Electrical System
§ Mechanical System
§ Process Equipment
§ Process Piping
§ Process Utilities
§ Other Components
§ Purpose of Facility
§ Aseptic Filling
§ Manufacturing
§ Research and Development
§ Others
§ Facility Area
§ Very Small
§ Small
§ Mid-Sized
§ Large
§ Very Large
§ Scale of Operation
§ Clinical
§ Commercial
§ Type of Industry
§ Pharmaceutical
§ Biotechnology
§ Type of Product
§ Biosimilars
§ Cell and Gene Therapies
§ Monoclonal Antibodies
§ Vaccines
§ Other Products
§ Type of Facility
§ New Facility
§ Facility Expansions
§ Key Geographical Regions
§ North America
§ Europe
§ Asia
§ Middle East and North Africa
§ Latin America
§ Rest of the World
To Request Sample Pages - https://www.rootsanalysis.com/reports/178/request-sample.html
Transcripts of interviews held with the following senior level representatives of stakeholder companies
§ Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular Construction)
§ François Abiven (Executive Vice-President Global Business Unit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)
§ Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)
§ Pär Almhem (President, Modwave)
§ Sulogna Roy (Ex Sales Manager, Zeton)
§ Vernon Solomon (Specialist in Modular Design for Cleanrooms and Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)
The Modular Facilities in Pharmaceutical and Biotechnology Market, 2021-2030 report features the following companies, which we identified to be key players in this domain:
§ Cytiva
§ G-CON Manufacturing
§ Pharmadule Morimatsu
§ NNE
§ IPM Technologies
§ KeyPlants
§ Germfree Laboratories
§ ModuleCO Pharma
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Modular Facility Manufacturers
5. Market Landscape: Modular Cleanroom Providers
6. Company Profiles
7. Partnerships and Collaborations
8. Feasibility Study
9. Facility Construction Trends in Pharmaceutical Industry
10. Market Forecast
11. Prevalent and Emerging Industry Trends
12. Future Growth Opportunities
13. Conclusion
14. Executive Insights
15. Appendix 1. Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html
Download Free Insights now - https://www.rootsanalysis.com/reports/178/free-insights.html
You may also be interested in the following titles:
1. Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
2. Biopharmaceutical CROs Market, 2021-2030
3. Continuous Manufacturing Equipment Providers Market, 2021-2030
